Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Federica Capozzi"'
Autor:
Alessandra Merlini, Maria Laura Centomo, Giulio Ferrero, Giulia Chiabotto, Umberto Miglio, Enrico Berrino, Giorgia Giordano, Silvia Brusco, Alberto Pisacane, Elena Maldi, Ivana Sarotto, Federica Capozzi, Cristina Lano, Claudio Isella, Giovanni Crisafulli, Massimo Aglietta, Angelo Paolo Dei Tos, Marta Sbaraglia, Dario Sangiolo, Lorenzo D’Ambrosio, Alberto Bardelli, Ymera Pignochino, Giovanni Grignani
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundAdvanced and unresectable bone and soft tissue sarcomas (BSTS) still represent an unmet medical need. We demonstrated that the alkylating agent trabectedin and the PARP1-inhibitor olaparib display antitumor activity in BSTS preclinical mode
Externí odkaz:
https://doaj.org/article/6963744e31cd41adb03a55107319c8e2
Autor:
Silvio Borrelli, Ida Matarazzo, Eugenio Lembo, Laura Peccarino, Claudia Annoiato, Maria Rosaria Scognamiglio, Andrea Foderini, Chiara Ruotolo, Aldo Franculli, Federica Capozzi, Pavlo Yavorskiy, Fatme Merheb, Michele Provenzano, Gaetano La Manna, Luca De Nicola, Roberto Minutolo, Carlo Garofalo
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 12, p 6378 (2022)
Increasing potassium intake ameliorates blood pressure (BP) and cardiovascular (CV) prognoses in the general population; therefore the World Health Organization recommends a high-potassium diet (90–120 mEq/day). Hyperkalaemia is a rare condition in
Externí odkaz:
https://doaj.org/article/9f763a41a46140dda1efc21cfbe843f4
Autor:
Ymera Pignochino, Federica Capozzi, Lorenzo D’Ambrosio, Carmine Dell’Aglio, Marco Basiricò, Marta Canta, Annalisa Lorenzato, Francesca Vignolo Lutati, Sandra Aliberti, Erica Palesandro, Paola Boccone, Danilo Galizia, Sara Miano, Giulia Chiabotto, Lucia Napione, Loretta Gammaitoni, Dario Sangiolo, Maria Serena Benassi, Barbara Pasini, Giovanna Chiorino, Massimo Aglietta, Giovanni Grignani
Publikováno v:
Molecular Cancer, Vol 16, Iss 1, Pp 1-15 (2017)
Abstract Background Enhancing the antitumor activity of the DNA-damaging drugs is an attractive strategy to improve current treatment options. Trabectedin is an isoquinoline alkylating agent with a peculiar mechanism of action. It binds to minor groo
Externí odkaz:
https://doaj.org/article/e058c6685da841f684afb510424d766a
Autor:
Giulia Mesiano, Giovanni Grignani, Erika Fiorino, Valeria Leuci, Ramona Rotolo, Lorenzo D’Ambrosio, Chiara Salfi, Loretta Gammaitoni, Lidia Giraudo, Alberto Pisacane, Sara Butera, Ymera Pignochino, Marco Basiricó, Federica Capozzi, Anna Sapino, Massimo Aglietta, Dario Sangiolo
Publikováno v:
OncoImmunology, Vol 7, Iss 11 (2018)
Metastatic bone and soft tissue sarcomas often relapse after chemotherapy (CHT) and molecular targeted therapy (mTT), maintaining a severe prognosis. A subset of sarcoma cancer stem cells (sCSC) is hypothesized to resist conventional drugs and sustai
Externí odkaz:
https://doaj.org/article/b80f241c9a02442ba99be91d08bc6b0f
Autor:
Giovanni Grignani, Massimo Aglietta, Piero Picci, Marco Alberghini, Stefano Ferrari, Franca Fagioli, Lorenzo D'Ambrosio, Erica Torchiaro, Dario Sangiolo, Loretta Gammaitoni, Stefania Bruno, Serena Marchiò, Marco Soster, Federica Capozzi, Marco Basiricò, Carmine Dell'Aglio, Ymera Pignochino
PDF file - 72K, Supplementary table 1. Percentage of wound healing closure calculated 16 hours after scratching osteosarcoma cell monolayers. * = p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c598b36d03534cb5a3225cbf58b4aad
https://doi.org/10.1158/1078-0432.22450569
https://doi.org/10.1158/1078-0432.22450569
Autor:
Giovanni Grignani, Massimo Aglietta, Piero Picci, Marco Alberghini, Stefano Ferrari, Franca Fagioli, Lorenzo D'Ambrosio, Erica Torchiaro, Dario Sangiolo, Loretta Gammaitoni, Stefania Bruno, Serena Marchiò, Marco Soster, Federica Capozzi, Marco Basiricò, Carmine Dell'Aglio, Ymera Pignochino
Purpose: The multikinase inhibitor sorafenib displays antitumor activity in preclinical models of osteosarcoma. However, in sorafenib-treated patients with metastatic-relapsed osteosarcoma, disease stabilization and tumor shrinkage were short-lived a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35d294eb5b59a4d259a99acc1f423f0f
https://doi.org/10.1158/1078-0432.c.6521967.v1
https://doi.org/10.1158/1078-0432.c.6521967.v1
Autor:
Giulia Chiabotto, Giovanni Grignani, Maja Todorovic, Valentina Martin, Maria Laura Centomo, Elisa Prola, Giorgia Giordano, Alessandra Merlini, Umberto Miglio, Enrico Berrino, Lucia Napione, Claudio Isella, Federica Capozzi, Marco Basiricò, Cristina Marsero, Ilaria Gerardi, Tiziana Venesio, Dario Sangiolo, Massimo Aglietta, Lorenzo D’Ambrosio, Ymera Pignochino
Publikováno v:
Cancers, Vol 12, Iss 6, p 1519 (2020)
Receptor tyrosine kinases (RTKs) inhibitors’ activity in advanced osteosarcoma is significant but short-lived. To prevent or at least delay drug resistance, we explored a vertical inhibition by combining drugs acting at different levels of the RTK
Externí odkaz:
https://doaj.org/article/142d257bfcd64755966ff8b60fce4fb1
Autor:
Lucia Napione, Massimo Aglietta, Umberto Miglio, Lorenzo D'Ambrosio, Federica Capozzi, Claudio Isella, Giulia Chiabotto, Elisa Prola, Tiziana Venesio, Maja Todorovic, Maria Laura Centomo, Giorgia Giordano, Enrico Berrino, Giovanni Grignani, Cristina Marsero, Marco Basiricò, Ymera Pignochino, Valentina Martin, Alessandra Merlini, Dario Sangiolo, Ilaria Gerardi
Publikováno v:
Cancers
Cancers, Vol 12, Iss 1519, p 1519 (2020)
Volume 12
Issue 6
Cancers, Vol 12, Iss 1519, p 1519 (2020)
Volume 12
Issue 6
Receptor tyrosine kinases (RTKs) inhibitors&rsquo
activity in advanced osteosarcoma is significant but short-lived. To prevent or at least delay drug resistance, we explored a vertical inhibition by combining drugs acting at different levels of
activity in advanced osteosarcoma is significant but short-lived. To prevent or at least delay drug resistance, we explored a vertical inhibition by combining drugs acting at different levels of
Autor:
Erika Fiorino, Anna Sapino, Giulia Mesiano, Sara Butera, Alberto Pisacane, Valeria Leuci, Massimo Aglietta, Loretta Gammaitoni, Lidia Giraudo, Federica Capozzi, Giovanni Grignani, Dario Sangiolo, Marco Basiricò, Lorenzo D'Ambrosio, Ymera Pignochino, Ramona Rotolo, Chiara Salfi
Publikováno v:
Oncoimmunology
OncoImmunology, Vol 7, Iss 11 (2018)
OncoImmunology, Vol 7, Iss 11 (2018)
Metastatic bone and soft tissue sarcomas often relapse after chemotherapy (CHT) and molecular targeted therapy (mTT), maintaining a severe prognosis. A subset of sarcoma cancer stem cells (sCSC) is hypothesized to resist conventional drugs and sustai
Autor:
Lucia Napione, Maria Serena Benassi, Giovanna Chiorino, Ymera Pignochino, Loretta Gammaitoni, Giovanni Grignani, Danilo Galizia, Erica Palesandro, Lorenzo D'Ambrosio, Marta Canta, Sandra Aliberti, Carmine Dell'Aglio, Barbara Pasini, Giulia Chiabotto, Francesca Vignolo Lutati, Annalisa Lorenzato, Marco Basiricò, Dario Sangiolo, Massimo Aglietta, Paola Boccone, Federica Capozzi, Sara Miano
Publikováno v:
Molecular Cancer
Molecular Cancer, Vol 16, Iss 1, Pp 1-15 (2017)
Molecular Cancer, Vol 16, Iss 1, Pp 1-15 (2017)
Background Enhancing the antitumor activity of the DNA-damaging drugs is an attractive strategy to improve current treatment options. Trabectedin is an isoquinoline alkylating agent with a peculiar mechanism of action. It binds to minor groove of DNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bac95fcb4d78dfaa034b6b64a689629
http://hdl.handle.net/2318/1636100
http://hdl.handle.net/2318/1636100